Olivier Brandicourt, newly appointed Chairman, Bayer HealthCare.
LEVERKUSEN, GERMANY: Bayer HealthCare has appointed Olivier Brandicourt as the Chairman of the Board of Management. Brandicourt will also serve as the member of the Bayer AG Executive Council, both the terms are effective from 1 November 2013. Since March 2013, Professor Wolfgang Plischke has led Bayer HealthCare on an interim basis in addition to his existing duties as a Bayer AG Board Member.
“With Olivier Brandicourt we have found a strong leader with outstanding international experience and a successful track record in the healthcare industry. I am convinced that he can significantly contribute to the further growth of our healthcare business,” said Dr. Marijn Dekkers, CEO, Bayer Group.
Brandicourt has 25 years of international experience in the pharmaceutical industry, including executive responsibilities in France, the United States, Canada and the United Kingdom. He has been a member of the Executive Leadership Team of Pfizer Inc, New York, US, for the last three years. Until recently he was President and General Manager of the Emerging Markets and Established Products Business Units. Before that he held senior operational positions as President of the Global Specialty Business Unit, and until 2012 he was head of the Global Primary Care Business Unit. Furthermore, he previously held senior regional and country management positions at Pfizer and positions across a range of disciplines including medical and marketing at Warner-Lambert/Parke-Davis.
© Worldofchemicals News